NIH, FDA Seeking Better Methods To Evaluate MedTech Innovations
This article was originally published in The Gray Sheet
Executive Summary
A new collaboration between the National Institutes of Health and FDA will spur research into new tools and methodologies to evaluate the safety and efficacy of innovative medical products